News | 08.11.2024
New Publication - European Radiology Experimental
Heimer at al. show that a novel intravenous Tantalum oxide nanoparticle contrast agent provides contrast advantages compared to opamidol for improved visualization of thoracic arteries and veins in a multiphase CT protocol.